TY - JOUR
T1 - Amyotrophic lateral sclerosis (ALS) swine models: Production and preliminary characterization
AU - Grindatto, A
AU - Perota, A
AU - Chieppa, Mn
AU - Costassa, Ev
AU - Colleoni, S
AU - Lo Faro, M
AU - Duchi, R
AU - Palmitessa, C
AU - Lagutina, I
AU - Tortarolo, M
AU - Lazzari, G
AU - Lucchini, Franco
AU - Bendotti, C
AU - Corona, C
AU - Galli, C
AU - Casalone, C.
PY - 2013
Y1 - 2013
N2 - Introduction. Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease that occurs in two forms: sporadic
and familial, the latter linked to mutations in the SOD1 gene.
As employment of transgenic SOD1 rodent models in ALS
research didn’t result in an improvement of patient prognosis,
another model, more closely related to human species, is strongly
demanded by the scientific community. On this basis, our group
produced, by Genetic Engineering and SCNT, transgenic blastocysts
and swine carrying the hSOD1G93A mutation, which is the
most frequently studied in rodents, since it reproduces patients
phenotype progression.
Materials and Methods. SCNT blastocysts on fifth day of
development were transplanted by midventral laparatomy to the
synchronized sows uterus. A cesarean delivery was performed at
the 114th day of gestation. In order to achieve a preliminary characterization
of our swine model, tissue banking was performed
on stillborn piglets and on animals that died soon after birth.
Immunocytochemistry on ear biopsy fibroblasts and western
blot on homogenized snap-shot frozen tissues (rabbit policlonal antibody 07–403 Millipore, concentration 1:200 and 1:1000
respectively) were performed. To assess SOD1G93A deposition
pattern Immunohistochemistry (rabbit policlonal antibody
GTX 100659; 1:250) and Immunofluorescence (GTX 100659;
1:250 and NeuN MAB377; 1:1000) were employed on FFPE tissues.
Genomic SOD1G93A swine DNA digested by SalI+BglII
(10 U/μg DNA) was hybridized with SOD-DIG probes
(20 ng/ml) to assess transgene integrations number by Southern
Blot.
Results and Conclusions. The transfer of 638 embryos
to eight recipient sows resulted in four pregnancies and in the
birth of 16 vital and 12 stillborn piglets (mean blastocyst development
to term efficacy, 8.78%). Five animals developed normally
while the remaining piglets died due to events commonly
reported in commercial herds. The transgenic protein expression
was confirmed by both immunocytochemistry and western
blot. Furthermore Southern blot revealed a transgene integration
number ranging from 1 to about 6 copies. IHC demonstrated
granular mutant protein aggregates in both perikarya and neurites
of neurons (nucleus labeled with NeuN in immunofluorescence
experiment) in brain (from area hypothalamica lateralis to
the third ventricle) and in spinal cord neurites.
Despite these encouraging results, further molecular and
pathological investigations are required since data have been
obtained in stillborn or extremely young animals. A detailed phenotypical
characterization, adapting to pig currently employed
human diagnostic devices, is in progress on adult living swine
AB - Introduction. Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease that occurs in two forms: sporadic
and familial, the latter linked to mutations in the SOD1 gene.
As employment of transgenic SOD1 rodent models in ALS
research didn’t result in an improvement of patient prognosis,
another model, more closely related to human species, is strongly
demanded by the scientific community. On this basis, our group
produced, by Genetic Engineering and SCNT, transgenic blastocysts
and swine carrying the hSOD1G93A mutation, which is the
most frequently studied in rodents, since it reproduces patients
phenotype progression.
Materials and Methods. SCNT blastocysts on fifth day of
development were transplanted by midventral laparatomy to the
synchronized sows uterus. A cesarean delivery was performed at
the 114th day of gestation. In order to achieve a preliminary characterization
of our swine model, tissue banking was performed
on stillborn piglets and on animals that died soon after birth.
Immunocytochemistry on ear biopsy fibroblasts and western
blot on homogenized snap-shot frozen tissues (rabbit policlonal antibody 07–403 Millipore, concentration 1:200 and 1:1000
respectively) were performed. To assess SOD1G93A deposition
pattern Immunohistochemistry (rabbit policlonal antibody
GTX 100659; 1:250) and Immunofluorescence (GTX 100659;
1:250 and NeuN MAB377; 1:1000) were employed on FFPE tissues.
Genomic SOD1G93A swine DNA digested by SalI+BglII
(10 U/μg DNA) was hybridized with SOD-DIG probes
(20 ng/ml) to assess transgene integrations number by Southern
Blot.
Results and Conclusions. The transfer of 638 embryos
to eight recipient sows resulted in four pregnancies and in the
birth of 16 vital and 12 stillborn piglets (mean blastocyst development
to term efficacy, 8.78%). Five animals developed normally
while the remaining piglets died due to events commonly
reported in commercial herds. The transgenic protein expression
was confirmed by both immunocytochemistry and western
blot. Furthermore Southern blot revealed a transgene integration
number ranging from 1 to about 6 copies. IHC demonstrated
granular mutant protein aggregates in both perikarya and neurites
of neurons (nucleus labeled with NeuN in immunofluorescence
experiment) in brain (from area hypothalamica lateralis to
the third ventricle) and in spinal cord neurites.
Despite these encouraging results, further molecular and
pathological investigations are required since data have been
obtained in stillborn or extremely young animals. A detailed phenotypical
characterization, adapting to pig currently employed
human diagnostic devices, is in progress on adult living swine
KW - Cu/Zn superoxide-dismutase1 (SOD1)
KW - amyotrophic lateral sclerosis (ALS)
KW - somatic cell nuclear transfer (SCNT)
KW - swine model
KW - Cu/Zn superoxide-dismutase1 (SOD1)
KW - amyotrophic lateral sclerosis (ALS)
KW - somatic cell nuclear transfer (SCNT)
KW - swine model
UR - http://hdl.handle.net/10807/61918
M3 - Conference article
SN - 1933-6896
VL - 7
SP - 63
EP - 64
JO - Prion
JF - Prion
T2 - PRION 2013
Y2 - 26 May 2013 through 29 May 2013
ER -